Virazole

Virazole is a brand name of ribavirin, approved by the FDA in the following formulation(s):

VIRAZOLE (ribavirin - for solution; inhalation)

• 
  Manufacturer: VALEANT PHARM INTL
  
  Approval date: December 31, 1985
  
  Strength(s): 6GM/VIAL ^[RLD]

Has a generic version of Virazole been approved?

No. There is currently no therapeutically equivalent version of Virazole available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Virazole. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes
  Patent 6,150,337
  Issued: November 21, 2000
  Inventor(s): Tam; Robert
  Assignee(s): ICN Pharmaceuticals, Inc.
  Ribavirin is employed in a manner which is effective to modulate lymphokine expression in activated T cells. In particular, Ribavirin is used to suppress Type 2-mediated T cell responses and promote Type 1-mediated T cell response. Thus, instead of administering Ribavirin in its well-recognized role as an anti-viral agent, Ribavirin is herein used in the treatment of imbalances in lymphokine expression. Such imbalances may be found to be concomitants of allergic atopic disorders such as allergic asthma and atopic dermatitis, helminth infection and leishmaniasis, and various primary and secondary immunodeficiencies, which may or may not also be associated with viral infection.
  
  Patent expiration dates:
  
  
  • November 21, 2017
    
    ✓ 
    Patent use: USE OF RIBAVIRIN TO INCREASE TYPE 1 CYTOKINE RESPONSE AND SUPPRESS TYPE 2 CYTOKINE RESP0NSE TO LYMPHOCYTES, INCLUDING METHODS THAT TAKE ADVANTAGE OF SUCH MODULATION TO TREAT INFECTIONS AND INFESTATIONS
  
  

See also...

• Virazole Solution Consumer Information (Wolters Kluwer)
• Virazole Advanced Consumer Information (Micromedex)
• Ribavirin Consumer Information (Wolters Kluwer)
• Ribavirin Capsules Consumer Information (Wolters Kluwer)
• Ribavirin Solution Consumer Information (Wolters Kluwer)
• Ribavirin Consumer Information (Cerner Multum)
• Ribasphere Ribapak Advanced Consumer Information (Micromedex)
• Ribavirin Advanced Consumer Information (Micromedex)
• Ribavirin Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Ribavirin AHFS DI Monographs (ASHP)